NIH researchers identify regulatory cells that shield against inflammatory bowel disease

• June 8, 2026

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

• May 12, 2026

• 7 min

Cross-species systems analysis distinguishes inflammatory remodeling from primary mucus secretory failure in inflammatory bowel disease

• by Jessica Xhumari, Amanda Ojeda, Oluwamayowa S. Akinsuyi, Luiz F. W. Roesch

• June 9, 2026

Evidence-based summary of optimal home self-management for elderly ostomy patients

• by Jiayi Feng, Fang Lu, Bo Zhou, Ji Li, Jian Shen, Lulu Tang, Yangyang Chen, Liping Kang, Guanghui Li, Zhaobei Wang, Huiqin Lin, Yuehua Gao

• June 1, 2026